Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
The question of whether nicotine, the neuroactive compound of tobacco, is addictive has been open to considerable scientific and public discussion. Although it can serve as a positive reinforcer in several animal species, including man, nicotine is thought to be a weak reinforcer in comparison with addictive drugs such as cocaine and heroin, and has been argued to be habit forming but not addictive. Here we report that intravenous nicotine in the rat, at doses known to maintain self-administration, stimulates local energy metabolism, as measured by 2-deoxyglucose autoradiography, and dopamine transmission, as estimated by brain microdialysis, in the shell of the nucleus accumbens. These neurochemical and metabolic effects are qualitatively similar to those of other drugs, such as cocaine, amphetamine and morphine, which have strong addictive properties. Our results provide functional and neurochemical evidence that there are specific neurobiological commonalities between nicotine and addictive drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nicotine elicits its psychoactive effects by activating neuromediators centrally (e.g. dopamine, serotonin, the catecholamines, etc.).”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Nicotine’s mode of action includes both psychostimulatory and sympathomimetic effects.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
In the citing paper
“Specifically, dopamine-rich brain regions representing the appetitive value of potential rewards such as the ventral striatum (Carlezon & Wise, 1996; Pontieri, Tanda, Orzi, & DiChiara, 1996; Wise, 2004; Galvan, et al., 2005; Haber & Knutson, 2009; Spicer, et al., 2007) show strong signaling during adolescence which may be indicative of earlier maturation (Galvan, et al., 2006; Geier, Terwilliger,”
From Frontostriatal maturation predicts cognitive control failure to appetitive cues in adolescents (2011) · cites this paper as Pontieri, Tanda, Orzi, & DiChiara, 1996
In the citing paper
“Nicotine administration leads to increased dopamine cell firing in the ventral tegmental area [15] and increased dopamine release in the nucleus accumbens [52], actions which are thought to be critical to the properties of nicotine as an addictive drug.”
From Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations (2017) · cites this paper as [52]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Handbook of Psychopharmacology
(1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,746
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes
Tiffany, S. T. (1990) · Psychological Review · doi:10.1037/0033-295x.97.2.147 · Cited by 1,554
Specificity in the projection patterns of accumbal core and shell in the rat
Heimer, L., Zahm, D. S., Churchill, L., Kalivas, P. W., & Wohltmann, C. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90202-y · Cited by 1,219
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Pontieri, F. E., Tanda, G., & Di Chiara, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12304 · Cited by 868
Self-citation
Research works printed but not linked: 1
- Orzi, F. et al. Eur. J. Pharmac. (in the press).
Cited by
Items 201–300 of 1,000
Lecca, D., Cacciapaglia, F., Valentini, V., Acquas, E., & Chiara, G. D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0496-y · Cited by 138
“…to rats at doses correspondent to those that support intravenous self-administration (SA), selectively or, depending on the dose, preferentially increases extracellular DA in a medial portion of the NAc corresponding to the shell as compared to the more laterally placed core (Pontieri et al. 1996).”
BackgroundSelf-citationMascia, P., Pistis, M., Justinova, Z., Panlilio, L. V., Luchicchi, A., Lecca, S., Scherma, M., Fratta, W., Fadda, P., Barnes, C., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.009 · Cited by 117
“Mesolimbic dopamine plays a pivotal role in nicotine dependence, and the VTA and nucleus accumbens shell are critical brain areas for nicotine's rewarding effects (37-39).”
BackgroundSelf-citationNeuropharmacological Actions of Cigarette Smoke: Brain Monoamine Oxidase B (MAO B) Inhibition
Fowler, J. S., Volkow, N. D., Wang, G., Pappas, N. R., Logan, J., MacGregor, R. R., Alexoff, D. L., Wolf, A. P., Warner, D., Cilento, R., et al. (1998) · Journal of Addictive Diseases · doi:10.1300/j069v17n01_03 · Cited by 137
Cholinergic connectivity: it's implications for psychiatric disorders
Scarr, E., Gibbons, A. S., Neo, J., Udawela, M., & Dean, B. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00055 · Cited by 119
“Systemic nicotine has been shown to increase dopamine release in the mesolimbic (Imperato et al., 1986; Damsma et al., 1989; Benwell and Balfour, 1994; Nisell et al., 1994a; Pontieri et al., 1996), nigrostriatal (Benwell and Balfour, 1994; Imperato et al.”
BackgroundRegional Cerebral Blood Flow Responses to Smoking in Tobacco Smokers After Overnight Abstinence
Zubieta, J.-K., Heitzeg, M. M., Xu, Y., Koeppe, R. A., Ni, L., Guthrie, S., & Domino, E. F. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.567 · Cited by 121
“Like other substances of abuse, nicotine increases extracellular dopamine levels in the nucleus accumbens in rats (9) and humans (10).”
BackgroundNicotine consumption is regulated by a human polymorphism in dopamine neurons
Morel, C., Fattore, L., Pons, S., Hay, Y. A., Marti, F., Lambolez, B., De Biasi, M., Lathrop, M., Fratta, W., Maskos, U., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.158 · Cited by 123
CB receptor antagonists for the treatment of nicotine addiction
Cohen, C., Kodas, E., & Griebel, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.024 · Cited by 133
“Because mesolimbic dopaminergic transmission is currently considered as a critical neuronal substrate in drug addiction (Pontieri et al., 1996), the interaction between nicotine and rimonabant on the dopamine transmission has been studied.”
BackgroundInfluentialChanges in brain activation associated with reward processing in smokers and nonsmokers
Martin-Söelch, C., Magyar‐Lehmann, S., Künig, G., Missimer, J. H., Schultz, W., & Leenders, K. L. (2001) · Experimental Brain Research · doi:10.1007/s002210100751 · Cited by 134
Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential?
Bernasconi, R. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01341-3 · Cited by 122
Locomotor response to novelty predicts a rat's propensity to self-administer nicotine
Suto, N., Austin, J., & Vezina, P. (2001) · Psychopharmacology · doi:10.1007/s002130100867 · Cited by 129
Quarta, D., Borycz, J., Solinas, M., Patkar, K., Hockemeyer, J., Ciruela, F., Lluis, C., Franco, R., Woods, A. S., Goldberg, S. R., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02761.x · Cited by 120
Hirsch, A. T., Treat-Jacobson, D., Lando, H. A., & Hatsukami, D. K. (1997) · Vascular Medicine · doi:10.1177/1358863x9700200314 · Cited by 120
Common aspects of the action of nicotine and other drugs of abuse
Picciotto, M. R. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00074-x · Cited by 117
Nicotine Receptor Inactivation Decreases Sensitivity to Cocaine
Zachariou, V., Caldarone, B. J., Weathers-Lowin, A., George, T. P., Elsworth, J. D., Roth, R. H., Changeux, J. P., & Picciotto, M. R. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00224-4 · Cited by 123
“In particular, the reinforcing effects of nicotine are thought to be mediated through activation of the mesolimbic dopamine (DA) system (Corrigall et al. 1994, 1992; Pontieri et al. 1996).”
BackgroundSignificant association of DRD1 with nicotine dependence
Huang, W., Ma, J. Z., Payne, T. J., Beuten, J., Dupont, R. T., & Li, M. D. (2007) · Human Genetics · doi:10.1007/s00439-007-0453-9 · Cited by 122
“…for Tobacco Treatment, Education and Research, University of Mississippi Medical Center, Jackson, MS, USA R. T. Dupont Department of Criminology and Criminal Justice, University of Memphis, Memphis, TN, USA thought to underlie smoking’s rewarding eVects (Nisell et al. 1994; Pontieri et al. 1996).”
BackgroundCannabinoid CB1 receptors are involved in motivational effects of nicotine in rats
Forget, B., Hamon, M., & Thiébot, M.-H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0015-6 · Cited by 125
“(NAcc), while having little or no effect in the core (Pontieri et al. 1996; Tanda et al. 1997; Iyaniwura et al. 2001), an effect that is claimed to correlate with the abuse liability of drugs (Di Chiara et al.”
BackgroundCNR1 Variation Modulates Risk for Drug and Alcohol Dependence
Zuo, L., Kranzler, H. R., Luο, X., Covault, J., & Gelernter, J. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.004 · Cited by 121
Elucidating the role of genetic factors in smoking behavior and nicotine dependence
Lerman, C., & Berrettini, W. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10003 · Cited by 114
“, 1997] and that nicotine’s effects on dopamine release are qualitatively similar to other abused substances [Pontieri et al., 1996].”
BackgroundJamal, M., van der Does, W. A. J., Cuijpers, P. J., & Penninx, B. W. J. H. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.05.001 · Cited by 127
Berríos‐Cárcamo, P., Quezada, M., Quintanilla, M. E., Morales, P., Ezquer, M., Herrera‐Marschitz, M., Israel, Y., & Ezquer, F. E. (2020) · Antioxidants · doi:10.3390/antiox9090830 · Cited by 121
“Nicotine Activate α4β2 or α6β2 nicotinic acetylcholine receptors in mesolimbic dopaminergic neurons [32], which promotes the release of dopamine in the nucleus accumbens [33].”
BackgroundLecca, D., Cacciapaglia, F., Valentini, V., Grønli, J., Spiga, S., & Chiara, G. D. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0280-4 · Cited by 120
“selectively increases extracellular DA in a medial portion of the NAc, corresponding to the shell, as compared to the more laterally placed core (Pontieri et al. 1996).”
BackgroundSelf-citationDopamine Enables In Vivo Synaptic Plasticity Associated with the Addictive Drug Nicotine
Tang, J., & Dani, J. A. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.025 · Cited by 103
“Nicotine-Induced Synaptic Potentiation Requires a Hippocampal Dopamine Signal Arriving from the Midbrain An important feature of nicotine’s addictive potential arises from nicotine-evoked firing of midbrain DA neurons, which produces a potent DA signal (Nestler, 2004; Nisell et al., 1994; Pontieri et al., 1996; Zhang…”
BackgroundDopaminergic and cholinergic learning mechanisms in nicotine addiction
Subramaniyan, M., & Dani, J. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12871 · Cited by 100
SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder
Krause, J. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.611 · Cited by 110
Rahman, S., Zhang, J., Engleman, E. A., & Corrigall, W. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.010 · Cited by 110
“administration of the drug suggest that nicotine produces greater increases in extracellular DA levels in the shell than in the core region of the ACB ( Pontieri et al., 1996 ).”
BackgroundInfluentialArroyo-Jiménez, M. D. M., Bourgeois, J.-P., Marubio, L. M., Le Sourd, A.-M., Ottersen, O. P., Rinvik, E., Fairén, A., & Changeux, J.-P. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06475.1999 · Cited by 110
“This mechanism may be relevant to brain reward circuits that plausibly could contribute to cognitive learning (Dehaene and Changeux, 1989, 1997; Levin et al., 1992, 1995) and nicotine addiction (Koob, 1996; Pontieri et al., 1996).”
BackgroundSmoking Behaviour and Mental Health Disorders—Mutual Influences and Implications for Therapy
Minichino, A., Bersani, F., Calò, W., Spagnoli, F., Francesconi, M., Vicinanza, R., Delle Chiaie, R., & Biondi, M. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10104790 · Cited by 104
“10%–24% for ADHD and non-ADHD, respectively) [45–48].”
Brain activity of anandamide: a rewarding bliss?
Scherma, M., Masia, P., Satta, V., Fratta, W., Fadda, P., & Tanda, G. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0075-x · Cited by 125
Self-citationChiamulera, C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.08.005 · Cited by 124
Cigarette smoking and schizophrenia
Kelly, C., & McCreadie, R. (2000) · Advances in Psychiatric Treatment · doi:10.1192/apt.6.5.327 · Cited by 105
Frosch, D. L., Shoptaw, S., Nahom, D., & Jarvik, M. E. (2000) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.8.1.97 · Cited by 112
The comorbidity of tobacco smoking and gambling: A review of the literature
MCGRATH, D. S., & BARRETT, S. P. (2009) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2009.00097.x · Cited by 100
Mathieu-Kia, A.-M., & Besson, M. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00338-0 · Cited by 112
Chronic tobacco smoking and neuropsychological impairments: A systematic review and meta-analysis
Conti, A. A., McLean, L., Tolomeo, S., Steele, J. D., & Baldacchino, A. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.11.017 · Cited by 117
Links Between Depression and Substance Abuse in Adolescents
Rao, U. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.07.002 · Cited by 122
Nehlig, A., & Boyet, S. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02480-4 · Cited by 120
Vandenbergh, D. J., O’Connor, R. J., Grant, M. D., Jefferson, A. L., Vogler, G. P., Strasser, A. A., & Kozlowski, L. T. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00054.x · Cited by 110
Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse?
Haydon, P. G., Blendy, J., Moss, S. J., & Rob Jackson, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.050 · Cited by 102
“…dopamine on motivation) and almost all drugs of abuse, including alcohol, nicotine, delta-9-tetrahydrocannabinol (THC), heroin and cocaine, can produce elevated dopamine levels in the nucleus accumbens (Di Chiara and Imperato, 1988;Koob and Bloom, 1988;Pontieri et al., 1996;Wise and Bozarth, 1987).”
BackgroundShim, I., Javaid, J. I., Wirtshafter, D., Jang, S.-Y., Shin, K.-H., Lee, H., Chung, Y.-C., & Chun, B. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00161-9 · Cited by 121
Discovery and development of varenicline for smoking cessation
Jordan, C. J., & Xi, Z. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1458090 · Cited by 113
“When administered alone, varenicline is 40–60% less efficacious in stimulating DA release in the NAc than nicotine, as shown by in vitro slice preparations as well as in vivo microdialysis [39].”
BackgroundInfluentialPathological mutations of nicotinic receptors and nicotine-based therapies for brain disorders
Léna, C., & Changeux, J. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80088-8 · Cited by 109
A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation
George, T. P., Vessicchio, J. C., Termine, A., Jatlow, P. I., Kosten, T. R., & O’Malley, S. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01454-3 · Cited by 106
The Neuronal Pathways Mediating the Behavioral and Addictive Properties of Nicotine
Balfour, D. J. K. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-69248-5_8 · Cited by 99
“Similar to other drugs of dependence, acute intravenous injections of nicotine to drug-naı̈ve animals stimulate DA overflow in the accumbal shell (as measured using microdialysis) but have little or no effect on DA overflow in the accumbal core (Pontieri et al. 1996).”
BackgroundThe neurobiological and behavioral overlaps of nicotine and food addiction
Criscitelli, K., & Avena, N. M. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.08.009 · Cited by 102
Region-specific transcriptional response to chronic nicotine in rat brain
Konu, Ö., Kane, J. K., Barrett, T., Vawter, M. P., Chang, R., Ma, J. Z., Donovan, D. M., Sharp, B. M., Becker, K. G., & Li, M. D. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02685-3 · Cited by 98
Pellicano, C., Pontieri, F. E., Fanciulli, A., & Buttarelli, F. R. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596612 · Cited by 97
“Stimulation of mesolimbic DA transmission is a common consequence of the administration of drugs of abuse belonging to different pharmacological classes to experimental animals [28-30] as well as humans [31].”
BackgroundSelf-citationCarboni, E., Bortone, L., Giua, C., & Di Chiara, G. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00064-2 · Cited by 96
“pared to the core (Pontieri et al., 1996).”
Self-citationThe role of the serotonin transporter gene in cigarette smoking.
Lerman, C., Shields, P. G., Audrain, J. E., Main, D., Cobb, B. G., Boyd, N. R., & Caporaso, N. E. (1998) · PubMed · Cited by 96
Gerasimov, M. R., Ashby, C. R., Gardner, E. L., Mills, M. J., Brodie, J. D., & Dewey, S. L. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199910)34:1<11::aid-syn2>3.0.co;2-5 · Cited by 96
A smoking cessation intervention for the methadone‐maintained
Stein, M. D., Weinstock, M. C., Herman, D. S., Anderson, B. J., Anthony, J. L., & Niaura, R. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01406.x · Cited by 94
Positive reactions to tobacco predict relapse after cessation.
Strong, D. R., Leventhal, A. M., Evatt, D. P., Haber, S. N., Greenberg, B. D., Abrams, D. B., & NIAURA, R. S. (2011) · Journal of Abnormal Psychology · doi:10.1037/a0023666 · Cited by 97
The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study
Montgomery, A. J., Lingford‐Hughes, A. R., Egerton, A., Nutt, D. J., & Grasby, P. M. (2007) · Synapse · doi:10.1002/syn.20419 · Cited by 95
“In common with many addictive substances, the addictive properties of nicotine may be associated with activation of the dopaminergic system (Balfour et al., 2000; Pontieri et al., 1996).”
BackgroundPanagis, G., Kastellakis, A., Spyraki, C., & Nomikos, G. G. (2000) · Psychopharmacology · doi:10.1007/s002130000384 · Cited by 107
“1996), extracellular DA levels (Imperato et al. 1986; Nisell et al. 1994a; Pontieri et al. 1996), local energy metabolism (Pontieri et al.”
InfluentialAllosteric nicotinic receptors, human pathologies
Léna, C., & Changeux, J. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80140-x · Cited by 111
Manzanares, J., Corchero, J., Romero, J., Fernández‐Ruíz, J., Ramos, J. A., & Fuentes, J. A. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00371-9 · Cited by 93
Gold, M. S., & Herkov, M. J. (1998) · Journal of Addictive Diseases · doi:10.1300/j069v17n01_02 · Cited by 94
Colilla, S., Lerman, C., Shields, P. G., Jepson, C., Rukstalis, M., Berlin, J., DeMichele, A., Bunin, G., Strom, B. L., & Rebbeck, T. R. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200506000-00004 · Cited by 93
Berrettini, W. H., Wileyto, E. P., Epstein, L. H., Restine, S., Hawk, L. W., Shields, P. G., NIAURA, R. S., & Lerman, C. E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.030 · Cited by 95
Neural Substrates and Circuits of Drug Addiction
Feltenstein, M. W., See, R. E., & Fuchs, R. A. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039628 · Cited by 100
“Similar effects occur during the self-administration of a variety of other drugs of abuse, including nicotine (Pontieri et al. 1996; Lecca et al. 2006b), cannabinoids (Fadda et al. 2006; Lecca et al. 2006a), and ethanol (Weiss et al. 1993; Melendez et al. 2002; van Erp and Miczek 2007).”
BackgroundTsukada, H., Miyasato, K., Kakiuchi, T., Nishiyama, S., Harada, N., & Domino, E. F. (2002) · Synapse · doi:10.1002/syn.10102 · Cited by 91
“One of the major conclusions of basic neuroscience research on drugs of abuse is that dopamine release in nucleus accumbens is a common synaptic mechanism of action (Pontieri et al., 1997).”
BackgroundTobacco Smoking within Psychiatric Inpatient Settings: Biopsychosocial Perspective
Olivier, D. H., Lubman, D. I., & Fraser, R. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701392809 · Cited by 110
“Nicotine, the main addictive component of tobacco, reaches the brain 10 s after inhalation, and stimulates dopamine release within the nucleus accumbens [14], most likely through activation of nicotinic acetylcholine receptors [15].”
BackgroundInteractions between nicotine and drugs of abuse: a review of preclinical findings
Kohut, S. J. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1209513 · Cited by 90
“levels of dopamine (DA) in discrete brain regions has been linked to a variety of its behavioral effects (31,32).”
BackgroundIn vivo Brain Imaging of Human Exposure to Nicotine and Tobacco
Sharma, A., & Brody, A. L. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-69248-5_6 · Cited by 91
“Microdialysis (Damsma et al. 1989; Di Chiara and Imperato 1988; Pontieri et al. 1996; Sziraki et al. 2001) and lesion (Corrigall et al. 1992) studies in rats indicate that nicotine-induced DA release is strongest in this region, and is more robust than the DA release found in associated structures…”
InfluentialDing, Y., Fowler, J. S., Logan, J., Wang, G., Telang, F., Garza, V., Biegon, A., Pareto, D., Rooney, W., Shea, C., et al. (2004) · Synapse · doi:10.1002/syn.20051 · Cited by 91
“…role and mechanisms by which they exert their actions and interactions with other transmitter systems are associated with various disease states, such as Parkinson’s disease, schizophrenia, Alzheimer’s disease (AD), and tobacco addiction (Domino, 1998; Peto et al., 1996; Pontieri et al., 1996).”
BackgroundPak, A. C., Ashby, C. R., Heidbreder, C. A., Pilla, M. A., Gilbert, J. G., Xi, Z., & Gardner, E. L. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006560 · Cited by 94
“This nicotine-enhanced meso-accumbens brain reward is mediated by increased DA in the reward-related nucleus accumbens (NAc) (e.g. Imperato et al., 1986; Pontieri et al., 1996; Yoshida et al., 1993).”
BackgroundChiara, G. D. (1997) · PubMed Central · Cited by 175
Self-citationMechanisms of Action of Drugs of Abuse on the Developing Fetal Brain
Malanga, C. J., & Kosofsky, B. E. (1999) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30070-8 · Cited by 97
Nussbaum, J. M., Xu, Q., Payne, T. J., Ma, J. Z., Huang, W., Gelernter, J. E., & Li, M. D. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn044 · Cited by 101
“Nicotine exerts its effect on the central nervous system by binding nicotinic acetylcholine receptors (6), and has been shown to increase dopamine levels in the nuclear accumbens (7).”
BackgroundWarburton, P., Baird, G., Chen, W., Morris, K., Jacobs, B. W., Hodgson, S., & Docherty, Z. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000403)96:2<228::aid-ajmg20>3.0.co;2-g · Cited by 72
Krause, K.-H., Dresel, S. H., Krause, J., Kung, H. F., Tatsch, K., & Ackenheil, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002821 · Cited by 88
“But there are numerous investigations demonstrating, that nicotine is an addictive drug, stimulating brain dopamine systems and increasing the firing of these cells as well as synthesis and release of dopamine in striatal regions (Gerasimov et al., 2000 ; Pontieri et al., 1996).”
BackgroundGenetics and Smoking Cessation
Lerman, C. E., Schnoll, R. A., & Munafo, M. R. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.09.006 · Cited by 97
Champtiaux, N., & Changeux, J. (2002) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007023339247 · Cited by 89
Garcés-Ramírez, L., Green, J. L., Hiranita, T., Kopajtic, T. A., Mereu, M., Thomas, A. M., Mesangeau, C., Narayanan, S., McCurdy, C. R., Katz, J. L., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.026 · Cited by 86
Self-citationYin, R., & French, E. D. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00237-9 · Cited by 96
Drug addiction: Functional neurotoxicity of the brain reward systems
Weiss, F., & Koob, G. F. (2001) · Neurotoxicity Research · doi:10.1007/bf03033235 · Cited by 96
Hancock, D. B., Reginsson, G. W., Gaddis, N. C., Chen, X., Saccone, N. L., Lutz, S. M., Qaiser, B., Sherva, R., Steinberg, S., Zink, F., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.149 · Cited by 85
Non-pharmacological factors that determine drug use and addiction
Ahmed, S. H., Badiani, A., Miczek, K. A., & Müller, C. P. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.08.015 · Cited by 89
“Nicotinic ACh-receptor stimulation has also a direct effect on mesolimbic DA activity (Pontieri et al., 1996; McBride et al. 1999; Wonnacott et al. 2000; Markou, 2008).”
BackgroundThe nucleus accumbens in reward and aversion processing: insights and implications
Xu, Y., Lin, Y., Yu, M., & Zhou, K. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2024.1420028 · Cited by 101
Grottick, A. J., & Higgins, G. A. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1174-3 · Cited by 86
“However, amongst other effects, the psychostimulants studied share the ability also to increase synaptic levels of both dopamine (Di Chiara and Imperato 1988; Pontieri et al. 1996; Okada et al. 1997a), and serotonin (Ribeiro et al. 1993; Summers and Giacobini 1995; Okada et al. 1997b), both of which will alter perform…”
BackgroundOhlmeier, M. D., Peters, K., Kordon, A., Seifert, J., Wildt, B. T., Wiese, B., Ziegenbein, M., Emrich, H. M., & Schneider, U. (2007) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm069 · Cited by 79
“Nicotine appears to have an effect on the nucleus accumbens similar to that of the amphetamine derivatives (Pontieri et al ., 1996).”
BackgroundPathophysiological Effects of Nicotine on the Pancreas: An Update
Chowdhury, P., Macleod, S. L., Udupa, K. B., & Rayford, P. L. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700708 · Cited by 96
“Nicotine activates nicotinic receptors that in tum enhance dopamine release in areas of the brain that are thought to be involved in reward (48-50).”
BackgroundBarrot, M., Marinelli, M., Abrous, D. N., Rougé‐Pont, F., Le Moal, M., & Piazza, P. V. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00525.x · Cited by 82
“© 1999 European Neuroscience Association, European Journal of Neuroscience , 11, 1155‐1166 Functional heterogeneity in the reactivity to challenges Hyper-reactivity of the shell It has been hypothesized that the nucleus accumbens shell is the striatal region that is the most responsive to drugs of abuse and stress (De…”
Janhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 98
Lecca, D., Cacciapaglia, F., Valentini, V., & Chiara, G. D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0475-3 · Cited by 99
“WIN 55,212-2 resembles delta9-THC in its ability to stimulate dopamine (DA) transmission in the shell of the nucleus accumbens (NAc) (Tanda et al. 1997), a property common to most, if not all, drugs of abuse ( Pontieri et al.1995, 1996 ).”
BackgroundSelf-citationSmoking and Nicotine Dependence
Nelson, C. B., & Wittchen, H.-U. (1998) · European Addiction Research · doi:10.1159/000018929 · Cited by 83
Disruption of nicotine conditioning by dopamine D3 receptor ligands
Foll, B. L., Jc, S., & Sokoloff, P. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001202 · Cited by 86
CHRNA3 rs1051730 Genotype and Short-Term Smoking Cessation
Munafo, M. R., Johnstone, E. C., Walther, D., Uhl, G. R., Murphy, M. F. G., & Aveyard, P. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr106 · Cited by 83
Decreased dopamine transporter availability in male smokers — A dual isotope SPECT study
Yang, Y. K., Yao, W. J., Yeh, T. L., Lee, I. H., Chen, P. S., Lu, R. B., & Chiu, N.-T. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.018 · Cited by 87
“The behavioral and neurobiological effects of tobacco smoking, in which nicotine may play an important role, are similar to those of addictive drugs (Pontieri et al., 1996).”
BackgroundChiara, V. D., Errico, F., Musella, A., Rossi, S., Mataluni, G., Sacchetti, L., Siracusano, A., Castelli, M., Cavasinni, F., Bernardi, G., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.141 · Cited by 90
Alteration of the Behavioral Effects of Nicotine by Chronic Caffeine Exposure
Tanda, G., & Goldberg, S. R. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00234-3 · Cited by 89
Self-citationNicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81
A neurocomputational hypothesis for nicotine addiction
Gutkin, B. S., Dehaene, S., & Changeux, J.-P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510220103 · Cited by 81
Schmidt, B. L., Tambeli, C. H., Gear, R. W., & Levine, J. D. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00264-0 · Cited by 85
Polymorphisms in genes involved in neurotransmission in relation to smoking
Arinami, T., Ishiguro, H., & Onaivi, E. S. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00816-5 · Cited by 93
Personality traits associated with caffeine intake and smoking
Gurpegui, M., Jurado, D., Luna, J. D. D., Fernández-Molina, C., Abril, O. M., & Gálvez, R. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.02.006 · Cited by 94
Chronic caffeine exposure potentiates nicotine self-administration in rats
Shoaib, M., SWANNER, L. S., Yaşar, S., & Goldberg, S. R. (1999) · Psychopharmacology · doi:10.1007/s002130050896 · Cited by 80
“Since an intravenous injection of nicotine selectively increases dopamine release and extracellular dopamine in the nucleus accumbens (Pontieri et al. 1996), antagonism of adenosine A2 receptor activity and the consequent reduction in inhibitory influences on central dopaminergic activity is a likely mechanism (Cardin…”
BackgroundInfluentialBlockade of Smoking Satisfaction Using the Peripheral Nicotinic Antagonist Trimethaphan
Rose, J. E., Westman, E. C., Behm, F. M., Johnson, M. P., & Goldberg, J. S. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00153-1 · Cited by 80
Nicotinic acetylcholine receptors: an overview on drug discovery
D’hoedt, D., & Bertrand, D. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902841045 · Cited by 82
“The key mechanism in addiction is the nicotine-induced release of dopamine (DA), a neurotransmitter known for its involvment in pleasure sensation and appetite suppression [92-99].”
BackgroundLiechti, M. E., & Markou, A. (2008) · CNS Drugs · doi:10.2165/00023210-200822090-00001 · Cited by 84
Greater sensitivity to subjective effects of nicotine in nonsmokers high in sensation seeking.
Perkins, K. A., Gerlach, D., Broge, M., Grobe, J. E., & Wilson, A. S. (2000) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.8.4.462 · Cited by 89
Metadata
- Authors
- Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D.
- Affiliations
- Sapienza University of Rome (IT)
- University of Cagliari (IT)
- Istituto Neurologico Mediterraneo (IT)
- Venue
- Nature
- Published
- 1996-07
- Volume
- 382
- Issue
- 6588
- Pages
- 255-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2000363595
- Cited by
- 1,073
- References
- 33
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 13 · 2023: 14 · 2022: 14 · 2021: 22 · 2020: 23 · 2019: 14 · 2018: 21 · 2017: 24 · 2016: 31 · 2015: 23 · 2014: 34 · 2013: 44 · 2012: 44
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotine, nicotine dependence, nucleus accumbens, energy metabolism, dopamine signaling, self-administration, cocaine, amphetamine, morphine, drug addiction, positive reinforcement, 2-deoxyglucose autoradiography, cerebral microdialysis
- MeSH terms
- Animals, Deoxyglucose, Dopamine, Energy Metabolism, Injections, Intravenous, Nicotine, Nucleus Accumbens, Microdialysis, Substance-Related Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.